Trade-Show Device Samples: Separate Demonstrators From Consumable Giveaways

Start with the intended use and final destination of each item

This guide is for a medical-device manufacturer, distributor or exhibition coordinator packing a booth shipment that mixes durable display equipment with sterile single-use products. The useful question is not whether the company is “going to a trade show.” It is whether each individual item will return, be consumed during a demonstration, be given away, or be sold.

Consider an illustrative crate containing a display model, a monitor, a reusable booth counter, sealed dressing samples, demonstration consumables and printed brochures. The freight may travel together, but the documentation should identify the different purposes. A brochure stack intended for visitors has a different planned outcome from a monitor that will return. A sterile pack reserved for a prospective distributor has a different outcome from a non-functional model kept behind the stand.

An ATA carnet can simplify temporary admission for eligible goods and avoid duty and tax payment at each participating border. It is one option: the International Trade Administration also identifies temporary import bonds and duty-drawback arrangements. The choice depends on the destination and use, not the event name.¹

Use two approvals in the packing plan: a customs route for the physical goods and a regulatory decision about what may be displayed, supplied or used. Assign a named owner to each. A freight release should never be interpreted by the sales team as a decision that every sample can now be handed to a visitor.

Split the manifest into three planning buckets

USCIB lists commercial samples, professional equipment and exhibition goods among carnet categories, while excluding consumables, disposables, giveaways and goods intended for repair or processing. “Commercial sample” in this setting can mean an item used to solicit orders and then returned; it does not mean every sample distributed for free.³

These are planning groups, not three universal statutory entry names. A country may allow a specific exhibition relief or another temporary-admission procedure; another may require an ordinary import declaration. The working manifest should therefore have a “route confirmed by” field rather than preprinting the same customs form for every market.

Do not move a sealed single-use product into the returnable group merely because one pack will remain unopened. Published issuer rules exclude disposable goods. Ask the issuer to assess any proposed display-only unit explicitly, including whether a purpose-built model is eligible. A “not for human use” sticker is an operational distinction, not an automatic customs exemption.³

Free samples need a customs decision and a device decision

Start with the destination’s written requirements, not the sample’s selling price. Irish Revenue, for example, offers permanent-import relief for samples used only as samples, of negligible value and intended to obtain orders. It still requires a description, commodity code and value for the declaration, and may require the samples to be made permanently unusable. That is a conditional relief, not a general exemption for anything marked “free sample.”¹¹

The practical implication for a sterile medical product is important: a customs relief that requires an unusable sample may suit a display prop but conflict with a proposed clinical-use sample. Do not alter a clinical product or its sterile barrier to pursue a customs concession and then hand it over as usable stock. Decide the permitted use first, and have the broker and regulatory owner agree a consistent route.

For the invoice or pro-forma documentation, distinguish “no charge to recipient” from the customs value. Provide the broker with the item description, quantity, purpose and a documented valuation basis; have the broker confirm the destination’s valuation method. Do not invent a nominal amount or assume that every jurisdiction uses replacement cost, wholesale price or cost-plus-freight in the same way.

Likewise, keep brochures and promotional goods identifiable on their own list. They should not disappear inside a line described only as “booth equipment.” Some samples may qualify for relief; requirements for promotional materials need separate confirmation. A conclusion that all promotional goods always incur full VAT and duty would be as misleading as a conclusion that free goods never do.^{11, 12}

Before authorizing handover of any device sample, record its intended purpose: display, non-clinical evaluation or patient use. These purposes should not be swapped at the booth. The exhibition checks below address showing devices; they do not establish a clinical investigation or routine supply pathway.

Make the returnable list identify the goods that will actually travel

The general list lets customs match the goods entering and leaving. HMRC’s handbook calls for identifying descriptions, model details, serial numbers where present, weights and values; it allows grouping identical items and provides an NSN notation where no serial number exists. Its valuation instructions distinguish new items from used items. These are useful specification prompts, rather than proof that every country requires a permanent serial number for every cable.¹⁰

• Describe the article, not only the container. “Exhibition case” should not conceal a model, monitor and accessories with different planned uses. Have the issuer approve the final grouping.
• Keep the model stable. Match photos and identifiers to the actual shipped version. If the factory substitutes another unit after the list is approved, ask the issuer how to correct the documents before dispatch.³
• Separate physical stock. Label the returnable and giveaway cartons with the manifest references. Keep a booth copy showing who may release each group.
• Plan every movement. Include transit and onward fairs, as well as the first destination and home return. Check document format, border office, representative and re-export deadline for each leg.⁷

A useful internal control is to photograph the packed returnable items and reconcile them before and after the show. Photographing a unit does not replace customs validation, but it helps the team explain a discrepancy without guessing which demonstrator or accessory disappeared.

Packaging has its own controls. The ISPM 15 guide for sterile-device shipments addresses wood packaging; it does not establish carnet eligibility or replace sterile-barrier evidence. Keep those approvals distinct in the shipment file.

Distinguish future orders from transfer of the display unit

A visitor can ask about ordering a product without taking possession of the display unit. USCIB describes commercial samples as items temporarily imported for demonstration or to solicit orders. Whether a specific order may be accepted also depends on the device’s regulatory and promotional status; a carnet does not decide that question.³

The customs problem changes when someone proposes to buy or retain the actual carnet-listed item. The International Trade Administration advises contacting local customs to regularize goods sold under a carnet. HMRC says a sale may exceptionally be allowed with permission and proper regularization, and that diversion should not be used routinely. Arrange that decision before transfer; a sales receipt alone does not close temporary admission.^{1, 12}

Give the booth team a short escalation rule: if a buyer asks to retain a returnable item, pause the handover and send the item reference to the customs owner and regulatory owner. If either approval is absent, keep the return plan. Do the same for donation, loss, destruction or a request to leave a model with a hospital; the manifest cannot silently absorb a change of purpose.

Check display permission separately from customs admission

For an EU fair, MDR Article 21(3) addresses showing a device that does not comply with the Regulation. It requires a visible sign explaining the presentation or demonstration purpose and that the device cannot be made available until compliant. This is a showing provision; it does not authorize supplying the device to a prospective customer.⁸

MDR Article 2(27) includes free supply within the definition of making available when supplied for distribution, consumption or use on the Union market during a commercial activity. A free sample therefore needs its own supply assessment. Do not infer that adding a sign to a booth makes a handover lawful or that Article 21 specifies one universal English placard for all situations.⁸

For the United States, FDA’s Regulatory Procedures Manual, section 9-18, describes requesting exhibition-only release of non-complying articles through the responsible FDA office and local CBP office, with supervised destruction or re-export after the event. It discusses a display placard advising of possible non-compliance and evaluates commercial-size shipments case by case. It is an agency procedure, not automatic permission granted by a “not for sale” label.⁹

For other destinations, request a product-specific answer from the responsible local regulatory contact before sending samples. This guide does not prescribe Chinese, UAE or Brazilian device exhibition permits. A country’s acceptance of ATA carnets tells the team about a customs instrument, not which health-regulator permission applies to a particular consumable.

Verify the 2026 itinerary and document format

ICC announced digital-carnet launch on 1 June 2026 across the EU’s 27 member states, Norway, Switzerland and the UK. Its roadmap lists UAE activation for 9 November 2026, which is still scheduled as of this review. ICC expects worldwide digital procedures by 1 January 2028; that is a transition target, not evidence that every border is already digital.^{5, 7}

Check the entire itinerary with the issuer. HMRC states that paper carnets issued before 1 June 2026 remain valid, and that formats during transition depend on the journey. Its technical handbook also identifies situations requiring both formats. The safe planning conclusion is to obtain itinerary-specific instructions, including the return leg, rather than discard a booklet because the destination appears on a digital-country list.^{13, 15}

This worksheet is deliberately a set of verified facts and open planning questions. It does not choose the destination declaration system, deposit, broker authorization or device permit. Recheck the ICC roadmap and the issuer’s country instructions before dispatch, especially for travel around the UAE activation date or a mixed paper/digital journey.

Treat missing closure evidence as a problem to resolve

CBP describes carnet exposure of 110% of duty and import taxes when listed goods are sold, donated or otherwise disposed of, with the guaranteeing association seeking recovery from the holder. Read that as an exposure measured against duties and taxes, not 110% of the device’s value. The International Trade Administration separately describes duties and taxes plus a 10% amount on a sale, with possible handling fees. These descriptions must not be added together as two automatic worldwide penalties.^{1, 2}

The amount and procedure in an actual case depend on the destination authority, circumstances and issuer’s terms. A missing stamp can lead to a claim, but it is not proof that goods were sold. An invoice, airline ticket or photograph may help explain what happened; ask the issuer what evidence customs will accept, rather than assume it automatically cures an omitted validation.^{2, 14}

Do not use the carnet’s usual validity period as the only calendar reminder. USCIB warns that foreign customs can impose shorter stays. Record the actual re-export date imposed for each admission and allow time to resolve a changed freight booking before that date.³

Use one manifest through dispatch, the booth and return

The following is a proposed internal workflow, not a statutory timetable. Its purpose is to keep the decisions made by logistics, regulatory staff and sales consistent. Add it to the exhibition file alongside the broker’s instructions.

1. Before the freight booking: Assign a manifest line to every article or approved group. Record description, identifier, quantity, proposed customs value/basis, planned use, destination, disposition and responsible person. Mark unresolved routes clearly.
2. Before carnet issuance: Have the issuer confirm goods eligibility and the full itinerary. Send the broker a separate list of giveaways, consumed stock and sale stock, with a request for entry, relief and valuation instructions.
3. Before packing: Obtain the regulatory assessment for each displayed and supplied device. Confirm any exhibition-release conditions and notices. Keep display models physically distinct from sample packs intended to leave the booth.
4. At each border: Present the goods and required documents for the relevant customs transaction. Check the item numbers and any imposed deadlines. For a mixed-format itinerary, keep the paper and digital records the issuer requires.^{14, 15}
5. During the event: Reconcile samples released against the approved list. Route requests to buy, retain, consume or donate returnable units to the shipment owner before any change.
6. After the event: Reconcile returnable items and leftovers. Obtain the applicable re-export and home-return validations; investigate omissions promptly with the issuer. Confirm discharge/return requirements for the carnet and retain the supporting file under the applicable instructions.¹⁴

A practical handoff to the booth manager is a list showing three things for each line: what can be handed over, what must come back, and who can authorize a change. Do not expect sales staff to infer these outcomes from a stack of freight documents. If a sample’s permitted use is still unresolved, keep it outside the visitor handover stock.

If a US entry is detained, follow the actual notice and release process; see the FDA device detention and release guide. A trade-show invitation, revised invoice or proposed relabeling does not by itself settle a detention.

Where VEMERIX fits—and where due diligence still begins

VEMERIX is the international brand of Weihai Medison Medical Equipment Co., Ltd., positioned as a Minimally Invasive Surgery Total Solution Platform serving urology, vascular surgery and perioperative care.

For a distributor or OEM discussion involving sterile single-use products, send the target country, event, exact product/variant, quantities and proposed sample purpose before requesting shipment. Identify which units would return and which would remain. Ask which product and shipment documents are available for that specific request, rather than assume a standard sample pack establishes local admissibility.

Use the VEMERIX contact page for a product-document or distributor enquiry and review the quality information. Carnet eligibility, customs declarations, valuation and local device permissions still need confirmation from the issuing association, broker and responsible regulatory contact. This guide does not promise brokerage, customs clearance or universal availability of a particular document.

Frequently asked questions

Can we put sterile giveaway samples on the carnet?
Do not list planned giveaways as returnable goods. CBP and USCIB exclude consumable or giveaway stock. Ask the destination broker to confirm its separate route and any conditional relief, then confirm that supplying the device itself is allowed.^{2, 3, 11}

Does a sealed single-use pack become eligible if we promise to return it?
A return intention does not override the issuer’s disposable-goods exclusion. Ask the issuer about the actual item; use a separately assessed display model where appropriate. Do not assume a demonstration label changes the product’s eligibility.³

Must we pay full duty and tax on every free sample?
No universal answer applies. Conditional reliefs exist; Irish Revenue’s sample relief is one example. Eligibility, declaration and valuation still need confirmation for the destination and intended use.¹¹

Can a visitor order the same model we display?
Customs guidance recognizes samples used to solicit orders. That differs from selling the physical carnet unit. Regulatory and promotional restrictions still apply to the product; get both decisions before accepting commitments or transferring stock.^{3, 12}

Do we still carry paper documents after the eATA launch?
Follow issuer instructions for the full itinerary. Earlier paper carnets can remain valid, and mixed journeys may require both formats. Do not treat a digital destination as proof that paper is unnecessary at every border.^{13, 15}

Is a customs stamp enough to authorize clinical use?
No. Customs admission and device-law permission address different decisions. The EU showing provision does not authorize making a non-compliant device available, and FDA exhibition release has its own conditions. Establish a separate lawful use or supply route before a sample leaves the exhibition plan.^{8, 9}